INDIA – Indian diagnostic company Mylab Discovery Solutions has announced plans to launch new vitro diagnostic (IVD) medical devices and kits designed to empower small laboratories across India.

Mylab will supply medical devices and reagents for use in small and medium size laboratories and clinics, enabling physicians to perform diagnoses at their facilities.

The IVD medical equipment including haematology, microbiology, immunology, and blood grouping applications.

In a press release, Mylab stated: “The company plans to roll out pan India through its network of distributors, and a highly trained and experienced sales force of more than 150 people.”

The medical equipment for small labs will allow in-house diagnostic testing without having to send samples to central labs or other cities, which increases the risk of spoiled samples and delayed reporting.

Mylab is introducing conventional diagnostic solutions to create a decentralized diagnostic ecosystem where medical technicians can use nearby facilities offering quality diagnostics at faster turn-around.

The company said that the tailor-made equipment will have smaller reagent packs, smaller sample volume requirements, better sensitivity, linearity, noting that they are point of care and high throughput.

Over the years, small laboratories have been using devices designed for big labs with high work load.

Therefore, labs and physicians with low workload had to collect samples and then send them in batches to central labs which are often not in the same city,” the company claimed.

Mylab seeks to tackle the logistic issues resulting in a long delay between sample collection and analysis.

According to the company, the diagnostics compLabs in semi-urban and rural areas in India can now offer specialised tests to patients.

The tailor-made equipment for small labs will also help patients from remote areas to access specialised tests easily at their home locations and avail timely treatment.

We plan to offer smaller, value for money packs of reagents for labs to drive volumes as was done by FMCG companies with their products,” said Rajesh Patel, Executive Director of Mylab.

The devices will utilize advanced technology enabling consumers to detect accurate levels of natural vitamins levels (Biotin) even if an individual is consuming vitamin supplements.

We have understood the gaps in existing offerings by existing IVD players and we are now well- positioned to empower laboratories with accelerated, cost-effective conventional IVD tests that can give results faster to physicians treating the patient,” Patel added.

For all the latest healthcare industry news from Africa and the World, subscribe to our NEWSLETTER, and YouTube Channel, follow us on Twitter and LinkedIn, and like us on Facebook.